CROI 2016 Program at a Glance

Index of Studies Related to Women

110LBSafety and Efficacy of DapivirineVaginal Ring for HIV-1 Prevention in AfricanWomen , Annalene Nel, Intl Partnership for Microbicides, Paarl, South Africa, et al. (Oral Abstracts Session O-9) 277 Immune Activation, CellTurnover, and Exhaustion in HIV+ WomenWith Heavy Alcohol Use , Seema N. Desai, Rush Univ Med Cntr, Chicago, IL, USA, et al. (Poster Abstracts Session P-C7) 438 Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and PostpartumWomen , Nikki Mulligan, Univ of California San Diego, San Diego, CA, USA, et al. (Poster Abstracts Session P-H2) 439 Rilpivirine Female GenitalTract Concentrations in Pregnant and PostpartumWomen , Mark Mirochnick, Boston Univ Sch of Med, Boston, MA, USA, et al. (Poster Abstracts Session P-H2) 444 Effect of CYP2B6 GeneVariants on Levonorgestrel PKWhen CombinedWith EFV-Based ART , Megan Neary, Univ of Liverpool, Liverpool, UK, et al. (Poster Abstracts Session P-H3) 448 Single-Dose Maraviroc Provides High Drug Levels in All Sites; No Gender Differences , Julie Fox, Guys and StThomas’NHS FndnTrust, London, UK, et al. (Poster Abstracts Session P-H4) 449 PK of FTC,TFV and 3TC in Ugandan and Nigerian Breastfeeding Mother-Infant Pairs , Catriona J.Waitt, Univ of Liverpool, Liverpool, UK, et al. (Poster Abstracts Session P-H4) 617 Global Burden of Cervical Cancer in HIV-PositiveWomen on AntiretroviralTherapy , Eliane Rohner, Inst of Social and Preventive Med, Univ of Bern, Bern, Switzerland, et al. (Poster Abstracts Session P-O1) 621 RandomizedTrial Comparing HIV-1 Cervical Shedding After CryotherapyVersus LEEP , Sharon A. Greene, Univ ofWashington, Seattle,WA, USA, et al. (Poster Abstracts Session P-O2) 622 Decline in Annual PapTesting Among HIV-PositiveWomen in Ontario, Canada , Ann N. Burchell, St Michael’s Hosp,Toronto, ON, Canada, et al. (Poster Abstracts Session P-O2) 623 Feasibility of Post-PartumTesting for HR-HPV Among HIV- Positive and -NegativeWomen , Laura J. Benjamins,The Univ ofTexas Med Sch at Houston, Houston,TX, USA, et al. (Poster Abstracts Session P-O2) 624 Role of p16Testing in Cervical Cancer Screening Among HIV- InfectedWomen , Christine J. McGrath, Univ ofTexas Med Branch at Galveston, Galveston,TX, USA, et al. (Poster Abstracts Session P-O2) 625 High Prevalence of HR-HPV Infection in HIV-InfectedWomen FromTanzania , Arne Kroidl, Univ of Munich, Munich, Germany, et al. (Poster Abstracts Session P-O2) 638 Persistently Increased Ischemic Stroke Risk in HIV-Infected Women ,Virginia A.Triant, Massachusetts General Hosp, Boston, MA, USA, et al. (Themed Discussion SessionTD-7) 706 Superior GlucoseTolerance and Metabolite Profiles inWomen vs Men on Long-Term ART , John R. Koethe,Vanderbilt Univ Sch of Med, Nashville,TN, USA, et al. (Poster Abstracts Session P-Q4) 757 Burden ofTuberculosis in HIV+ Pregnant & PostpartumWomen in CapeTown, South Africa , Landon Myer, Univ of CapeTown, Cape Town, South Africa, et al. (Poster Abstracts Session P-R8) 758 Pregnancy Intensifies the IFN-gamma Suppression of HIV in TB-Infected IndianWomen , Jyoti S. Mathad,Weill Cornell Med Coll, NewYork, NY, USA, et al. (Poster Abstracts Session P-R8)

790 Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study , Muktar H. Aliyu,Vanderbilt Inst for Global Hlth, Nashville,TN, USA, et al. (Poster Abstracts Session P-S5) 791 RandomizedTrial of a Lay Counselor-Led Combination Intervention for PMTCT Retention , Ruby N. Fayorsey, ICAP, Columbia Univ Mailman Sch of PH, NewYork, NY, USA, et al. (Poster Abstracts Session P-S5) 792 Continuity of Care Among PregnantWomen Lost to Follow-up After Initiating ART , Kate Clouse,Vanderbilt Inst for Global Hlth, Nashville,TN, USA, et al. (Poster Abstracts Session P-S5) 793 Disclosure and Knowledge Are AssociatedWith Retention in Malawi’s Option B+ Program , Risa M. Hoffman, Univ of California Los Angeles, Los Angeles, CA, USA, et al. (Poster Abstracts Session P-S5) 794 Initiating cART in Pregnancy: Impact on HIV RNA Decay , Jasmini Alagaratnam, St Mary’s Hosp, Imperial Coll NHSTrust, London, UK, et al. (Poster Abstracts Session P-S6) 795 Viraemic Episodes Occur Frequently in Postpartum South African Women on ART , Landon Myer, Univ of CapeTown, CapeTown, South Africa, et al. (Poster Abstracts Session P-S6) 796 Viral Suppression and Retention 2–5Years After ART Initiation in Pregnancy in Uganda , Catherine A. Koss, Univ of California San Francisco, San Francisco, CA, USA, et al. (Poster Abstracts Session P-S6) 797 HIV Resistance in PregnantWomenWith Detectable HIV-1 RNA at Delivery in Mozambique , Maria Ruperez, Barcelona Inst for Global Hlth, Barcelona, Spain, et al. (Poster Abstracts Session P-S6) 798 MaternalVitamin D Deficiency Is AssociatedWith Preterm Birth in HIV-InfectedWomen , Jennifer Jao, Icahn Sch of Med at Mount Sinai, NewYork, NY, USA, et al. (Poster Abstracts Session P-S7) 799 Timing of ART Initiation in Pregnancy and Birth Outcomes in South AfricanWomen , Landon Myer, Univ of CapeTown, CapeTown, South Africa, et al. (Poster Abstracts Session P-S7) 803 Mortality Risk AssociatedWith Preterm and SGA Stratified by Maternal HIV Status , Ayesha Sania, ICAP, Columbia Univ Mailman Sch of PH, NewYork, NY, USA, et al. (Poster Abstracts Session P-S7) 804 HBV and HCV Infections in HIV-Infected PregnantWomen: Obstetrical Outcomes ,Valerie Benhammou, INSERM 1153, PARIS, France, et al. (Poster Abstracts Session P-S7) 833 Psychological Reactance Is a Novel Risk Factor for Adolescent HIVTreatment Failure , Elizabeth D. Lowenthal, Univ of Pennsylvania Perelman Sch of Med, Philadelphia, PA, USA, et al. (Poster Abstracts Session P-T4) 871 Phase ITrial to Assess Safety, PK, and PD of Film and Gel Formulations ofTenofovir , Katherine E. Bunge, Univ of Pittsburgh, Pittsburgh, PA, USA, et al. (Poster Abstracts Session P-V2) 872 Safety and Pharmacokinetics of DapivirineVaginal Rings in Postmenopausal USWomen , Beatrice A. Chen, Univ of Pittsburgh, Pittsburgh, PA, USA, et al. (Poster Abstracts Session P-V2) 873 Adherence and Acceptability of a DapivirineVaginal Ring in Postmenopausal USWomen , Ariane van der Straten, RTI, San Francisco, CA, USA, et al. (Poster Abstracts Session P-V2) 875 A First-in-HumanTrial of PC-1005 (MIV-150 and Zinc Acetate in a Carrageenan Gel) , Barbara A. Friedland, Pop Council, NewYork, NY, USA, et al. (Poster Abstracts Session P-V2)

Index of Studies Related toWomen

CROI 2016 135